Work

Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement

Year: 2007

Type: article

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428190601059720

Authors: Jodi V. Mones, Morton Coleman, Lale Kostakoglu, Richard R. Furman, Amy Chadburn, Tsiporah B. Shore, Daniel Muss, Patricia Stewart, Stewart Kroll, Shankar Vallabhajosula, Stanley J. Goldsmith, John P. Leonard

Institutions: NewYork–Presbyterian Hospital, Cornell University, Weill Cornell Medicine, Corixa Corporation

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Center for Research Resources

Awards: G2409183021, Novel Monoclonal Antibody Therapies for Lymphoma

OpenAlex ID: W1967417752

FWCI: 1.756

Cites: 31

Cited by: 14

Related to: 10